Indicative Announcement on Convening the 2025 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on Convening the 2025 Annual General Meeting
Filed with SSE · · 11 pages · Chinese
Release
Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix
Earlier from Hubei Jumpcan Pharmaceutical
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Receipt of Drug Registration Application Acceptance Notice
- Announcement on Resolutions of the 20th Meeting of the 10th Board of Directors
- Announcement on Self-exercise Results and Changes in Share Capital of 2022 Restricted Stock and Stock Option Incentive Plan in Q1 2026
- Announcement on Progress in Wholly-owned Subsidiary Using Idle Raised Funds for Cash Management
Later from Hubei Jumpcan Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Approval of Pudilan Xiaoyan Oral Liquid as a National Protected Traditional Chinese Medicine Variety
- Indicative Announcement on Expiration of the 2nd Lock-up Period of 2024 Employee Stock Ownership Plan
- Indicative Announcement on Restricted Exercise Period for the Stock Options Initially Granted in 2022 Restricted Stock and Stock Option Incentive Plan
- Announcement on Completion of Non-trading Transfer under the 2026 Employee Stock Ownership Plan
Follow Hubei Jumpcan Pharmaceutical into a list and get an email when it puts out news.
Follow Hubei Jumpcan Pharmaceutical